0001193125-22-023358 Sample Contracts

ATHIRA PHARMA, INC. AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • January 31st, 2022 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington

• Contract Type
  Change in Control and Severance Agreement
• Filed
  January 31st, 2022
• Company
  Athira Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Washington

This Amended and Restated Change in Control and Severance Agreement (the “Agreement”) is effective as of January 31, 2022 (the “Effective Date”), and amends and restates the Change in Control and Severance Agreement by and between Athira Pharma, Inc., a Delaware corporation (the “Company”), and Mark Litton (“Executive”), dated as of September 8, 2020 (the “Prior Agreement”).